Can I Take L-Theanine with Vyvanse? A Clinical Review

Updated Jul 14, 2025

Image: HealthRX.com clinical image

At a glance

Drug / Vyvanse (lisdexamfetamine dimesylate), a Schedule II CNS stimulant, FDA-approved for ADHD and moderate-to-severe binge eating disorder in adults
Supplement / L-theanine, a non-protein amino acid found in green and black tea (Camellia sinensis), sold as an unregulated dietary supplement
Interaction type / No established pharmacokinetic interaction; a plausible but untested pharmacodynamic overlap
Primary theoretical concern / Additive CNS sedation at higher L-theanine doses; a theoretical (unproven) blunting of stimulant arousal
Doses used in general L-theanine research / Roughly 100 to 400 mg per day, mostly in studies not involving stimulant co-administration
Vyvanse activation / Converted to active d-amphetamine by red-blood-cell enzymes after oral dosing, not primarily by liver enzymes
Direct safety data on this specific combination / Not established; no dedicated trials or systematic pharmacovigilance signal identified in the sources reviewed for this page
Disclosure / Tell your prescriber or pharmacist before adding any supplement to a Schedule II stimulant

What L-theanine is, and why people on Vyvanse consider it

L-theanine (gamma-glutamylethylamide) is an amino acid concentrated in tea leaves. It is commonly described in the supplement and nutrition literature as producing a state of calm alertness rather than sedation, and as increasing alpha-wave EEG activity at commonly used doses. People taking Vyvanse sometimes add it hoping to reduce the anxiety, irritability, or "wired" feeling that can accompany amphetamine-class stimulants, particularly around the time of peak drug effect.

This is a reasonable rationale grounded in general pharmacology, but reasonable rationale is not the same as direct evidence for this pairing. The sections below separate what is established, what is plausible, and what is unproven.

The core answer, with its boundary

Vyvanse is a prodrug: after swallowing, it is converted to active d-amphetamine mainly through enzymatic activity associated with red blood cells, with metabolism of the released d-amphetamine occurring afterward. L-theanine is not established as an inhibitor or inducer of the enzyme systems involved in that process, so a pharmacokinetic interaction, meaning a change in Vyvanse or d-amphetamine blood levels, is not expected on mechanistic grounds. The open question is pharmacodynamic: both compounds influence dopamine, norepinephrine, and glutamate signaling, though through different mechanisms, and no clinical trial identified for this review has tested the combination directly. Reassurance for typical L-theanine doses comes mainly from adjacent evidence, caffeine-combination studies and ADHD-population studies of L-theanine alone, rather than from direct testing with lisdexamfetamine, so individual monitoring and disclosure to a prescriber remain necessary rather than optional.

Why a pharmacokinetic interaction is unlikely

Vyvanse's FDA-approved prescribing information identifies specific interaction concerns for lisdexamfetamine: monoamine oxidase inhibitors (contraindicated), and agents that alter urinary pH, such as sodium bicarbonate (which can raise d-amphetamine levels by reducing renal clearance) or ascorbic acid and ammonium chloride (which can lower them). Dietary amino acid supplements such as L-theanine are not listed among these concerns. L-theanine is absorbed through intestinal amino acid transporters, a different route than the mechanisms governing amphetamine's central nervous system entry, and no competitive interference between the two has been documented. This is a mechanistic and labeling-based inference, not a statement that the combination has been formally studied and cleared.

The pharmacodynamic question: what could plausibly happen

This is the part of the interaction that is genuinely unresolved.

Dopamine and norepinephrine. D-amphetamine produces large increases in synaptic dopamine and norepinephrine by reversing transporter activity, which underlies both its therapeutic effect and its side-effect profile. L-theanine's effects on dopamine and norepinephrine at typical supplemental doses are described in the literature as modest by comparison. Because the magnitude of the two effects is very different, a therapeutic dose of Vyvanse is unlikely to be meaningfully counteracted by ordinary L-theanine doses, but "unlikely" is a mechanistic judgment, not a tested clinical outcome.

Glutamate and calming effects. D-amphetamine can raise glutamatergic tone in ways that contribute to anxiety at higher plasma levels. L-theanine is reported to have NMDA-receptor antagonism and mild GABA-supportive activity, which is the most plausible mechanistic explanation for why some users report less jitteriness when combining the two. This remains a plausible mechanism inferred from L-theanine's general pharmacology, not a finding demonstrated in Vyvanse users specifically.

Sedation at higher doses. Doses of L-theanine well above the ranges typically studied (roughly above 400 mg/day) are reported anecdotally and in some literature to produce drowsiness in sensitive individuals. Combining sedation with a stimulant creates competing effects on arousal that have not been characterized in trials, which is a reason to favor the lower end of commonly used doses if trying this combination at all.

What the evidence base actually consists of, and its limits

No clinical trial identified for this article enrolled patients taking Vyvanse and tested L-theanine as an add-on. The available literature clusters into three adjacent areas, and each has a specific limitation when applied to this question:

L-theanine plus caffeine. Caffeine is a much weaker stimulant than amphetamine, acting on adenosine receptors rather than directly releasing catecholamines. Studies in this area have generally reported that adding L-theanine to caffeine does not blunt caffeine's cognitive benefits and may reduce jitteriness. This is a proof of concept that a calming supplement need not cancel out a stimulant, but the pharmacology of caffeine and amphetamine differs enough that direct extrapolation is not sound.
L-theanine in ADHD populations without stimulant co-administration. Some pediatric and adult studies have looked at L-theanine's effects on sleep and anxiety in people with ADHD, generally without combining it with a stimulant medication. These studies can speak to L-theanine's standalone tolerability in ADHD populations but cannot speak to what happens when it is layered on top of an active stimulant.
General pharmacovigilance. No specific safety signal for the lisdexamfetamine plus L-theanine combination was identified in the sources reviewed for this page. Absence of a reported signal is consistent with, but does not prove, safety, especially for a combination that is not commonly reported as a discrete product pairing in adverse event systems.

Because the specific trial identifiers, sample sizes, and effect sizes commonly cited for L-theanine research could not be verified against primary sources for this review, this article deliberately avoids attaching precise numbers (exact patient counts, p-values, or point estimates) to specific studies. A clinician or pharmacist relying on this page for a patient conversation should verify any specific trial claim directly against the primary literature before citing it as fact.

Evidence boundary: what is established, plausible, and unknown

Established: Vyvanse's FDA-approved labeling identifies MAO inhibitors and urinary pH-altering agents as clinically significant interaction concerns; L-theanine is not among them. Vyvanse is activated through red-blood-cell enzymatic conversion rather than a pathway L-theanine is known to affect.

Plausible but unproven for this combination: L-theanine's glutamate- and GABA-related calming mechanisms could reduce stimulant-related anxiety in some users without meaningfully reducing therapeutic benefit at commonly used doses. This is inferred from L-theanine's general pharmacology and from adjacent caffeine-combination research, not demonstrated directly.

Not established: Whether L-theanine changes ADHD symptom control, binge-eating outcomes, or cardiovascular measures when taken alongside Vyvanse specifically; the safety and effect profile of L-theanine doses above those typically studied when combined with a stimulant; and the effect of this combination in children, in people with bipolar disorder or psychosis history, or in people on serotonergic medications, none of whom have combination-specific data.

Evidence-Status Interaction Assessment: L-Theanine and Vyvanse

Question	Status	Basis	What to verify
Does L-theanine change Vyvanse or d-amphetamine blood levels?	Not expected, based on mechanism	No shared enzyme pathway identified between L-theanine and lisdexamfetamine's activation/metabolism	Confirm current FDA labeling has not changed; ask pharmacist to check for updated interaction data
Does L-theanine reduce stimulant-related anxiety when taken with Vyvanse?	Plausible, unproven for this pairing	Adjacent caffeine-combination and standalone ADHD studies; L-theanine's known glutamate/GABA effects	No trial has tested this in Vyvanse users; treat as an individual trial-and-monitor question
Does L-theanine blunt Vyvanse's therapeutic effect?	Not established, low mechanistic concern at typical doses	Magnitude mismatch between amphetamine's catecholamine release and L-theanine's modest dopaminergic effect	Track a symptom scale (see monitoring section) before and after adding L-theanine
Is there a serious safety signal from this specific combination?	No documented signal found, absence is not proof of safety	No combination-specific adverse event data identified in review	Ask prescriber whether newer pharmacovigilance data exists
Is high-dose L-theanine (above roughly 400 mg/day) safe with a stimulant?	Unknown	No dose-ranging safety data for this combination	Do not exceed doses used in general L-theanine research without medical guidance
Is this combination studied in children, or in bipolar disorder, psychosis history, or serotonergic medication use?	Not established	No combination-specific pediatric or high-risk-population data identified	Requires individualized prescriber or psychiatrist input before use

Who should talk to a prescriber before trying this

People on serotonergic medications. L-theanine has been described as having mild serotonin-modulating activity in some literature. Anyone taking SSRIs, SNRIs, buspirone, or other serotonergic drugs should mention any new supplement to their prescriber, since increasing serotonergic activity from multiple directions is a recognized general concern, even when any single added agent is mild.

People with bipolar disorder or a history of psychosis. Vyvanse carries an FDA boxed warning class of concerns around psychiatric risk, including new or worsened psychosis or mania in susceptible individuals. Adding any CNS-active supplement in this population deserves psychiatric input rather than self-directed trial.

Children and adolescents. Data on L-theanine in ADHD-diagnosed children exist, but not in combination with a stimulant. A pediatric prescriber should weigh this absence of combination data before endorsing L-theanine as an add-on to a child's stimulant regimen.

People using Vyvanse for binge eating disorder. L-theanine's effects on appetite and impulse-control circuitry in this indication have not been evaluated. Anyone using Vyvanse for this FDA-approved indication should discuss any supplement addition with the prescribing clinician and monitor appetite and eating behavior if one is added.

If you and your prescriber decide to try it

Timing and dose separation are not required from a pharmacokinetic standpoint, since no such interaction is established. A cautious, evidence-anchored approach some clinicians use informally, though it has not itself been tested in trials, is to start at the lower end of doses used in general L-theanine research (roughly 100 to 200 mg per day), taken near the time of the morning Vyvanse dose, and to avoid combination products that pair L-theanine with other CNS-active ingredients unless a prescriber has reviewed the full ingredient list.

A practical way to judge whether the combination is helping, doing nothing, or causing harm is to track a small set of measures before starting and again after four to six weeks:

ADHD symptom control, using a standardized self-report scale your prescriber can supply or recommend
Anxiety symptoms, using a standardized brief anxiety scale
Sleep quality
Resting heart rate and blood pressure
A simple log of any new or worsened symptoms (drowsiness, fatigue, mood change, cognitive fog) with timing relative to dosing

Bring this record to your next visit rather than adjusting doses on your own. Seek urgent care for chest pain, fainting, severe agitation, signs of serotonin syndrome (such as high fever, muscle rigidity, or marked confusion), or new psychotic symptoms; these are not expected outcomes of this combination but are reasons to stop and seek emergency evaluation regardless of the suspected cause.

Key takeaways

There is no established pharmacokinetic interaction between L-theanine and Vyvanse, based on their known metabolic pathways and current FDA labeling for lisdexamfetamine. There is a mechanistically plausible pharmacodynamic overlap, both affect dopamine, norepinephrine, and glutamate signaling, but no dedicated trial has tested the combination, so claims about benefit or blunting of stimulant effect in this specific pairing remain unproven rather than disproven. Anyone considering this combination should disclose it to their prescriber, favor doses within ranges used in general L-theanine research, and track objective measures rather than assuming a favorable or unfavorable outcome in advance.

Frequently asked questions

Can I take L-theanine while on Vyvanse?

There is no established pharmacokinetic interaction, meaning L-theanine is not expected to change Vyvanse blood levels. No dedicated trial has tested the combination for safety or effect, so this should be discussed with your prescriber and monitored individually rather than assumed safe or effective.

Does L-theanine interact with Vyvanse?

Not through drug metabolism, based on current FDA labeling and known pharmacology. A pharmacodynamic overlap is plausible because both affect dopamine, norepinephrine, and glutamate signaling, but this overlap has not been studied directly in people taking both together.

Is L-theanine safe with Vyvanse?

No documented safety signal for this specific combination was identified in the sources reviewed for this article, but absence of a reported signal is not the same as proven safety. People with bipolar disorder, a history of psychosis, or those on serotonergic medications should consult their prescriber before adding L-theanine.

Will L-theanine make Vyvanse less effective?

This has not been tested directly. Mechanistically, the catecholamine surge from a therapeutic Vyvanse dose is much larger than L-theanine's modest effects on the same systems, which makes meaningful blunting seem unlikely at typical L-theanine doses, but this is an inference rather than a demonstrated finding.

What dose of L-theanine has been studied in general research?

Human studies of L-theanine alone (not combined with Vyvanse) have generally used doses in the range of roughly 100 to 400 mg per day. There is no dose specifically established as appropriate or tested for use alongside a stimulant.

Can children take L-theanine with Vyvanse?

Some research has looked at L-theanine in children with ADHD, but not combined with stimulant medication. No pediatric combination data exist, so a pediatric prescriber should be consulted before adding L-theanine to a child's stimulant regimen.

What should I monitor if I try this combination?

Track ADHD symptom control, anxiety symptoms, sleep quality, and resting heart rate and blood pressure before starting and again after four to six weeks, along with a log of any new or worsened symptoms. Share this with your prescriber rather than adjusting the regimen on your own.

Are there supplements that do have a known interaction with Vyvanse?

Yes. Vyvanse's FDA-approved labeling identifies monoamine oxidase inhibitors as contraindicated, and notes that urine-alkalinizing agents such as sodium bicarbonate can raise d-amphetamine levels while urine-acidifying agents such as high-dose ascorbic acid or ammonium chloride can lower them. These are pharmacokinetic interactions, unlike L-theanine's purely pharmacodynamic profile.

A note on sources: the citations attached to specific trial details (author names, exact sample sizes, and precise statistical results) in earlier drafts of this topic could not be verified against the primary literature for this review and have been removed or generalized rather than repeated. Anyone using this page to inform a clinical decision should verify specific trial claims directly with a pharmacist, prescriber, or the primary literature before relying on them, and should treat this article as background orientation pending qualified medical review, not as a substitute for individualized advice.